You are here: Industry Insights > neurological disorders

News List

Ben-Gurion University Introduces Novel Combination Therapy for Treating Neurological Disorders americanpharmaceuticalreview
May 16, 2019
BGN Technologies has introduced a novel drug combination therapy, based on two FDA approved drugs, for protecting the blood-brain-barrier ...
Biogen signs two deals to address neurological disorders pharmaceutical-technology
January 08, 2019
Biogen has signed a strategic collaboration with US-based drug maker C4 Therapeutics for the discovery and development of new therapies to treat neurological diseases, including Alzheimer’s disease.
First Subject Dosed in Phase I Study of HTL0014242 americanpharmaceuticalreview
December 14, 2018
Sosei Group announces that the first healthy subject has been dosed with a novel small molecule HTL0014242 in a Phase I clinical study.....
Berg work with AstraZeneca to identify new therapeutic targets to treat neurological disorders cphi-online
August 30, 2017
Collaboration to focus on a disease target in Parkinson's disease.
New method identifies potential targets in neurological disorders fiercebiotech
August 28, 2017
Baylor scientists targeted an overabundance of the MeCP2 protein to reverse symptoms of a neurological disorder in mice.
GeNeuro initiates Phase 2a study in Australia to treat Type 1 Diabetes europeanpharmaceuticalreview
April 20, 2017
GeNeuro, a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, have started a Phase 2a clinical study in Australia with GNbAC1 in patients with Type 1 diabetes.